These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 20393367
21. Predictors of adherence with antihypertensive and lipid-lowering therapy. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS. Arch Intern Med; 2005 May 23; 165(10):1147-52. PubMed ID: 15911728 [Abstract] [Full Text] [Related]
22. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. Mechtouff L, Touzé E, Steg PG, Ohman EM, Goto S, Hirsch AT, Röther J, Aichner FT, Weimar C, Bhatt DL, Alberts MJ, Mas JL, REACH Registry Investigators. J Intern Med; 2010 Jun 23; 267(6):621-33. PubMed ID: 20210837 [Abstract] [Full Text] [Related]
25. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy? Agarwal S, Tang SS, Rosenberg N, Pettitt D, McLaughlin T, Joyce A, Schwartz JS. Am J Ther; 2009 Jun 23; 16(2):119-26. PubMed ID: 19114872 [Abstract] [Full Text] [Related]
28. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA. Am J Geriatr Pharmacother; 2009 Oct 23; 7(5):262-70. PubMed ID: 19948302 [Abstract] [Full Text] [Related]
29. The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Cherry SB, Benner JS, Hussein MA, Tang SS, Nichol MB. Value Health; 2009 Jun 23; 12(4):489-97. PubMed ID: 18783393 [Abstract] [Full Text] [Related]
30. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain. Wu N, Chen S, Boulanger L, Fraser K, Bledsoe SL, Zhao Y. J Med Econ; 2009 Sep 23; 12(3):192-202. PubMed ID: 19705975 [Abstract] [Full Text] [Related]
31. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. Kang HY, Ko SK, Liew D. Clin Ther; 2009 Dec 23; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032 [Abstract] [Full Text] [Related]
32. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S. Arthritis Rheum; 2006 Dec 23; 54(12):3790-8. PubMed ID: 17136752 [Abstract] [Full Text] [Related]
33. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. Med Care; 2010 May 23; 48(5):409-17. PubMed ID: 20393360 [Abstract] [Full Text] [Related]
35. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. Stock SA, Stollenwerk B, Redaelli M, Civello D, Lauterbach KW. J Womens Health (Larchmt); 2008 Apr 23; 17(3):343-54. PubMed ID: 18338965 [Abstract] [Full Text] [Related]